Concepedia

Paul Legendre

PL

Statistics

Publications

18

Citations

2K

H-Index

13

Active since

2001

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Hôpital Cochin

Université Paris Cité

Inserm

Sorbonne Université

Paul Legendre is an author at Assistance Publique – Hôpitaux de Paris specializing in immunology, pharmacotherapy, and infectious diseases.

ORCID

Publications per year

2001–2023

18

Publications

18

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

, , +14

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier et al. · BMJ · 2020 · 460 citations · Full text

, , +15

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

, , +14

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial

Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier et al. · medRxiv · 2020 · 164 citations · Full text

, , +13

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal et al. · Genome Medicine · 2023 · 77 citations · Full text

, , +17

1–5 of 18